TY  - CONF

T1  - The cost effectiveness of adalimumab (HUMIRA (R)) in patients with RA: A Finnish analysis

JO  - ANNALS OF THE RHEUMATIC DISEASES

PY  - 2004/07/01

AU  - Bansback NJ

AU  - Brennan A

AU  - Sengupta N

ED  - 

VL  - 63

SP  - 513

EP  - 514

Y2  - 2024/12/26

ER  -